The Lovelace Biomedical Research Institute was awarded a $18,397 cost plus fixed fee delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Lovelace to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $20,168 delivery order to Lovelace Biomedical Research Institute under the Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity master contract. Lovelace will perform guaranteed minimum work related to advancing pediatrics and HIV prevention science from April 2023 through June 2024 in Albuquerque, New Mexico. The...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $716,374 delivery order contract to Lovelace Biomedical Research Institute. Under the terms of the firm fixed price contract, Lovelace Biomedical Research Institute will conduct a Good Laboratory Practice repeat dose toxicology study for BPL-24910 in support of the Comprehensive and Rapid Response for NIAID Research Programs major program code. Performance...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $486,301.00 cost-plus-fixed-fee delivery order contract to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization. Under this contract, the Lovelace Biomedical Research Institute will perform the transfer, validation, and qualification of bioanalytical methods for the detection of cabotegravir and levonorgestrel in rat and nonhuman primate plasma. This work is being conducted...
This task order funds the guaranteed minimum amount under a preexisting master indefinite-delivery/indefinite-quantity contract between the National Institutes of Health's National Institute of Allergy and Infectious Diseases and Advanced Bioscience Laboratories, Inc. The purpose is to support preclinical and translational vaccine development for HIV and other candidate agents. The $2,500 delivery order was awarded on December 1, 2021 with a one-year period of performance ending November 30,...
This task order, awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Southern Research Institute, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle. The purpose of this delivery order is to provide preclinical services in support of HIV therapeutics research and development efforts. With a potential value of $0.00 and cost-no-fee pricing, this task...
This task order funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle with the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The $0 potential value indicates the order is funding pre-established contract capacity rather than discrete services. Alchem Laboratories Corporation will perform the preclinical services as the prime contractor, with place of performance in Alachua, Florida. No set-aside...
This is a task order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The task order, titled "PRE-CLINICAL MODELS OF INFECTIOUS DISEASES TASK ORDER B07", is part of NIAID's Preclinical Models of Infectious Diseases contract vehicle, which provides...
This federal contract award is for a Delivery Order under the National Institute of Allergy and Infectious Diseases (NIAID) Animal Models of Infectious Diseases 2010-2017 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The $1,513,255.77 cost-plus-fixed-fee contract was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute, to provide a non-human primate model for testing the immunogenicity and...
This is a task order contract award to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS). The contract, valued at $57,500.00, is for management support activities related to the BIO-AMT-2301 Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. This vehicle supports ASPR with a wide...